Population Health Council Meeting Health Enhancement Community
March 12, 2020
Population Health Council Meeting Health Enhancement Community - - PowerPoint PPT Presentation
Population Health Council Meeting Health Enhancement Community March 12, 2020 Agenda Item Lead Time Mins OHS Welcome, Introductions, and Meeting Purpose 10:00 10:10 10 HMA HEC: Progress Since the Release of the HEC Framework HMA
Population Health Council Meeting Health Enhancement Community
March 12, 2020
2
Item Lead Time Mins
Welcome, Introductions, and Meeting Purpose OHS HMA 10:00 – 10:10 10 HEC: Progress Since the Release of the HEC Framework HMA 10:10 – 11:35 85 HEC Status Overview HMA 10:10 – 10:20 10 HEC Pre-Planning Communities HMA 10:20 – 10:35 15 HEC Funding Strategies HMA 10:35 – 10:55 20 HEC Financial Model HMA 10:55 – 11:10 15 HEC Measurement Development HMA 11:10 – 11:20 10 Feedback and Discussion OHS HMA 11:20 – 11:50 30 Next Steps and Adjourn All 11:50 – 12:00 10
3
4
level planning and Technical Assistance
Impact Model to tell us if the HEC Initiative makes economic sense for Connecticut and potentially inform considerations around reinvestment opportunities.
5
6
the Hospital Anchor Institution strategy that is now starting
various stakeholders including the Connecticut Hospital Association.
7
develop key elements of an HEC for their community (Scope 1)
8
9
Awardees Phase 1 Scope* Nov 1 – Jan 31 Bridgeport Hospital/YNHHS Scope 1 & 2 Charlotte Hungerford Hospital Scope 1 City of Hartford, DHHS Scope 1 & 2 Ledge Light Health District Scope 1 Middletown Board of Education Scope 1 Mid Fairfield Child Guidance, Inc. Scope 1 Southern Connecticut State University Scope 1 & 2 StayWell Health Center, Inc. Scope 1 Uncas Health District Scope 1
* Scope 1 – Main grant; Scope 2 – Rapid Cycle Measures
10
the HEC health priority aims
geographic boundary with which it would be beneficial to align
11
directly by community members.
population outcomes at the local community level.
12
data aligned with HEC measurement guidance
13
14
and administration
near-term and long-term resources
decisions about the scale and timing
15
16
Planning Funds Implementation Funds Long-Term/Sustainable Financing
17
SIM and OHS funds and philanthropic grants to design and develop HECs Braided and blended funds to align existing programs, wellness trust grants and investments to
for TA Prevention Savings Program to reinvest savings into initiative and HECs, tax credits, health-related tax revenue, braided and blended funds
CT FUNDERS CONSORTIUM
Public-private partnership comprising funders from across CT contributing funds.
from funders with vested interest in CT and communities
(braiding or blending) funders’ existing funding priorities and commitments
and investors
mechanism for aligning funders and pooling funds and absorbing future infusions (e.g., portions of an opioid settlement, health-related tax).
National Funders Investors* Funds for All HECs, Multiple HECs, or One HEC Funds for to Administer HEC Initiative Funds for Statewide Interventions CT Funders
Philanthropy, corporate giving, community benefit, etc. * Option if long-term funds are secured.
18
inform such strategies.
20
21
term and long-term savings impact of the HECs on Medicaid spending, both per capita and total
scores for the Medicaid population without HEC interventions
including state employees and dependents
22
Strengths
eligibility data that is then summarized into major groupings for analysis
certain individuals who are dually eligible for Medicare and Medicaid and some state only expenses (not federally matched) Limitations
an ACE, are likely underreported
23
Key Takeaways
24
Source: CHN Developed Dataset for CT Medicaid Population
Total Program 400,000 450,000 500,000 550,000 600,000 650,000 700,000 750,000 800,000 850,000 900,000 2012 2013 2014 2015 2016 2017 2018
Average # of Medicaid Members Over Time (2012 – 2018) Total
<1 1-8 9-20 21-44 45-64 65+
100,000 150,000 200,000 250,000 300,000 2012 2013 2014 2015 2016 2017 2018
Average # of Medicaid Members Over Time (2012 – 2018) By Age Band
4.6% for all age groups from 2012 – 2018 is driven by adults age 21 to 64
rate of 7.3% driven primarily by HUSKY D (Adult ACA Expansion Group)
decrease (-0.5% average annual growth)
25
Source: CHN Developed Dataset for CT Medicaid Population Dollar amounts adjusted for non-system claims including: Rx Rebates, GME, TPL
$261 Non-ACEs Child $372 ACEs Child $262 Non-Obese Child $454 Obese Child $1,008 Non-Obese Adult $1,276 Obese Adult $- $200 $400 $600 $800 $1,000 $1,200 $1,400
PMPM Cost Condition & Age Band
Relative Cost of ACEs or Obesity 7 Year Average PMPM (2012 - 2018)
Medical LTSS Rx
member with an ACE or Obesity is pronounced when compared to members without these conditions
expensive than a child without an ACE
expensive than a child without obesity
expensive than an adult without obesity ➢ When excluding LTSS—services that are predominantly utilized by Medicaid members 65+—the cost
the cost of an adult without
Key Takeaways
26
Opportunity to Bend the Cost Curve by Reducing Future Prevalence Rates
Savings are dependent on statewide prevention strategies and success of HECs interventions
Obese Adults Prevalence, with Intervention 37.7% 37.4% Obese Adults Prevalence, Absent Intervention 44.4% Obese Children, with Intervention 23.5% 20.7% Obese Children, Absent Intervention 27.7% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 50.0% 2018 2020 2022 2024 2026 2028 2030
Reduction in Prevalence Rates in Model Adult Obesity, Childhood Obesity
Adult Obesity Childhood Obesity
ACEs Prevalence, with Intervention 36.6% 40.7% ACEs Prevalence, Absent Intervention 40.7% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 2018 2020 2022 2024 2026 2028 2030
Reduction in Prevalence Rates in Model Children with ACEs
Children with ACEs
Reduction in Prevalence Rates in Model (Low Savings Scenario) Adult Obesity, Childhood Obesity Reduction in Prevalence Rates in Model (Low Savings Scenario) Children with ACES
27
Medicaid Per Capita Cost projections are estimated using trends from the CMS Office of the Actuary and exclude LTSS Dollar amounts are adjusted for Rx Rebates, GME and TPL in the model; assumes HEC interventions fully implemented by January 2023
$684 $664 $300 $350 $400 $450 $500 $550 $600 $650 $700 $750 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Medicaid PMPM Cost Projection (Low Savings Scenario) with and without Interventions
Baseline PMPM Costs (Actual) Baseline PMPM Costs (Projected) Scenario 1 PMPM
HEC Impact Model Projections Summary: Medicaid PMPM Savings
➢ Preliminary analysis suggests that the HEC Initiative has the potential to reduce Medicaid spending by 1.8% to 2.8%, over the time period through 2030.
Years 2012 – 2018 Source: CHN Developed Dataset for CT Medicaid Population
Low Savings PMPM
$3.0 $4.0 $5.0 $6.0 $7.0 $8.0 $9.0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Medicaid Expenditures (in Billions) Year
Total Medical Expenditures by Year by Cost Saving Scenario (in Billion Dollars)
Baseline Total Costs (Actual) Baseline Total Costs (Projected) Low Savings Medium Savings High Savings
28
➢ Total cumulative savings over the time period through 2030 range between $1.1B and $1.9B* from improvements in the overall health of the Medicaid population
HEC Impact Model Projections: Medicaid Expenditures Savings Scenarios
Years 2016 – 2018 Source: CHN Developed Dataset for CT Medicaid Population Expenditures exclude LTSS Dollar amounts are adjusted for Rx Rebates, GME and TPL in the model; assumes HEC interventions fully implemented by January 2023
29
SHIP and other state/national initiatives and data sources
recommended a process to revise measures over time based on factors such as experience and funder input
additional data sharing agreements and collaboration are required to collect and analyze measures
agreements for later stages
conjunction with rapid cycle measures for short to intermediate term
30
H E A LT H M A N AG E M E N T A S S O C I AT E S
31